{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:13Z","timestamp":1792788133634,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Shapingba District Health Commission","award":["2023SQKWLH021"],"award-info":[{"award-number":["2023SQKWLH021"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-22-12"],"award-info":[{"award-number":["320.6750.2022-22-12"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Program of Chongqing","award":["YXGD202403"],"award-info":[{"award-number":["YXGD202403"]}]},{"name":"Talent Program of Chongqing","award":["cstc2024rcih-bgzxm0162"],"award-info":[{"award-number":["cstc2024rcih-bgzxm0162"]}]},{"name":"Chongqing Health Commission","award":["2023MSXM043"],"award-info":[{"award-number":["2023MSXM043"]}]},{"name":"Scientific and Technological Research Program of Chongqing Municipal Education Commission","award":["KJQN20230013"],"award-info":[{"award-number":["KJQN20230013"]}],"id":[{"id":"https:\/\/ror.org\/031nm5713","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Health Alliance Charitable Foundation","award":["BJHA-CRP-089"],"award-info":[{"award-number":["BJHA-CRP-089"]}]},{"name":"Chongqing Science and Technology Bureau","award":["cstc2022jxjl20039"],"award-info":[{"award-number":["cstc2022jxjl20039"]}]},{"DOI":"10.13039\/100016834","name":"Chongqing Municipal Health Commission","doi-asserted-by":"publisher","award":["2023ZDXM029"],"award-info":[{"award-number":["2023ZDXM029"]}],"id":[{"id":"10.13039\/100016834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Project for Enhancing Scientific Research Capabilities of Chongqing University Cancer Hospital","award":["2023nlts009"],"award-info":[{"award-number":["2023nlts009"]}],"id":[{"id":"https:\/\/ror.org\/023rhb549","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02178-8","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:45:17Z","timestamp":1782801917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An organoid-guided platform for ovarian cancer: enabling prediction of patients\u2019 chemotherapy response"],"prefix":"10.1186","volume":"19","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-1421","authenticated-orcid":false,"given":"Haixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-8783","authenticated-orcid":false,"given":"Dongling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2178_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.21824","volume":"74","author":"DS Dizon","year":"2024","unstructured":"Dizon DS, Kamal AH. Cancer statistics 2024: All hands on deck. CA Cancer J Clin. 2024;74:8\u20139. https:\/\/doi.org\/10.3322\/caac.21824.","journal-title":"CA Cancer J Clin"},{"key":"2178_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","volume":"81","author":"AJ Cortez","year":"2018","unstructured":"Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81:17\u201338. https:\/\/doi.org\/10.1007\/s00280-017-3501-8.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2178_CR3","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primer. 2016;2:16061. https:\/\/doi.org\/10.1038\/nrdp.2016.61.","journal-title":"Nat Rev Dis Primer"},{"key":"2178_CR4","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, et al. Epithelial ovarian cancer experimental models. Oncogene. 2014;33:3619\u201333. https:\/\/doi.org\/10.1038\/onc.2013.321.","journal-title":"Oncogene"},{"key":"2178_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","volume":"24","author":"N Sachs","year":"2014","unstructured":"Sachs N, Clevers H. Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev. 2014;24:68\u201373. https:\/\/doi.org\/10.1016\/j.gde.2013.11.012.","journal-title":"Curr Opin Genet Dev"},{"key":"2178_CR6","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim M, Mun H, Sung CO, Cho EJ, Jeon H-J, Chun S-M, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10:3991. https:\/\/doi.org\/10.1038\/s41467-019-11867-6.","journal-title":"Nat Commun"},{"key":"2178_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","volume":"14","author":"N Maenhoudt","year":"2020","unstructured":"Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models. Stem Cell Rep. 2020;14:717\u201329. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.004.","journal-title":"Stem Cell Rep"},{"key":"2178_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a Living Organoid Biobank of colorectal cancer patients. Cell. 2015;161:933\u201345. https:\/\/doi.org\/10.1016\/j.cell.2015.03.053.","journal-title":"Cell"},{"key":"2178_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell. 2018;172:373\u2013e38610. https:\/\/doi.org\/10.1016\/j.cell.2017.11.010.","journal-title":"Cell"},{"key":"2178_CR10","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","volume":"28","author":"K L\u00f5hmussaar","year":"2021","unstructured":"L\u00f5hmussaar K, Oka R, Espejo Valle-Inclan J, Smits MHH, Wardak H, Korving J, et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. Cell Stem Cell. 2021;28:1380\u2013e13966. https:\/\/doi.org\/10.1016\/j.stem.2021.03.012.","journal-title":"Cell Stem Cell"},{"key":"2178_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper O, de Witte CJ, L\u00f5hmussaar K, Valle-Inclan JE, Hami N, Kester L, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25:838\u201349. https:\/\/doi.org\/10.1038\/s41591-019-0422-6.","journal-title":"Nat Med"},{"key":"2178_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104013","author":"K Hoffmann","year":"2020","unstructured":"Hoffmann K, Berger H, Kulbe H, Thillainadarasan S, Mollenkopf H, Zemojtel T, et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low\u2010Wnt environment. EMBO J [Internet]. 2020. https:\/\/doi.org\/10.15252\/embj.2019104013. [cited 2022 May 5];39.","journal-title":"EMBO J [Internet]"},{"key":"2178_CR13","doi-asserted-by":"publisher","first-page":"107762","DOI":"10.1016\/j.celrep.2020.107762","volume":"31","author":"CJ de Witte","year":"2020","unstructured":"de Witte CJ, Espejo Valle-Inclan J, Hami N, L\u00f5hmussaar K, Kopper O, Vreuls CPH, et al. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses. Cell Rep. 2020;31:107762. https:\/\/doi.org\/10.1016\/j.celrep.2020.107762.","journal-title":"Cell Rep"},{"key":"2178_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.20892\/j.issn.2095-3941.2021.0621","volume":"19","author":"H Li","year":"2022","unstructured":"Li H, Liu H, Chen K. Living biobank-based cancer organoids: prospects and challenges in cancer research. Cancer Biol Med. 2022;19:965\u201382. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2021.0621.","journal-title":"Cancer Biol Med"},{"key":"2178_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/DCR.0000000000001971","volume":"64","author":"T Wang","year":"2021","unstructured":"Wang T, Pan W, Zheng H, Zheng H, Wang Z, Li JJ, et al. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study. Dis Colon Rectum. 2021;64:833\u201350. https:\/\/doi.org\/10.1097\/DCR.0000000000001971.","journal-title":"Dis Colon Rectum"},{"key":"2178_CR16","doi-asserted-by":"publisher","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","volume":"11","author":"SN Ooft","year":"2019","unstructured":"Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11:eaay2574. https:\/\/doi.org\/10.1126\/scitranslmed.aay2574.","journal-title":"Sci Transl Med"},{"key":"2178_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L, et al. Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. Cell Stem Cell. 2020;26:17\u2013e266. https:\/\/doi.org\/10.1016\/j.stem.2019.10.010.","journal-title":"Cell Stem Cell"},{"key":"2178_CR18","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","volume":"25","author":"CA Pasch","year":"2019","unstructured":"Pasch CA, Favreau PF, Yueh AE, Babiarz CP, Gillette AA, Sharick JT, et al. Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clin Cancer Res Off J Am Assoc Cancer Res. 2019;25:5376\u201387. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3590.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2178_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","volume":"45","author":"L Xian","year":"2022","unstructured":"Xian L, Zhao P, Chen X, Wei Z, Ji H, Zhao J, et al. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer. Cell Oncol Dordr Neth. 2022;45:1019\u201336. https:\/\/doi.org\/10.1007\/s13402-022-00707-3.","journal-title":"Cell Oncol Dordr Neth"},{"key":"2178_CR20","doi-asserted-by":"publisher","first-page":"e2204097","DOI":"10.1002\/advs.202204097","volume":"9","author":"S Mo","year":"2022","unstructured":"Mo S, Tang P, Luo W, Zhang L, Li Y, Hu X, et al. Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy. Adv Sci Weinh Baden-Wurtt Ger. 2022;9:e2204097. https:\/\/doi.org\/10.1002\/advs.202204097.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2178_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","volume":"24","author":"S Nuciforo","year":"2018","unstructured":"Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, et al. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies. Cell Rep. 2018;24:1363\u201376. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.001.","journal-title":"Cell Rep"},{"key":"2178_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","volume":"8","author":"SJ Hill","year":"2018","unstructured":"Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG, Worley MJ, et al. Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018;8:1404\u201321. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0474.","journal-title":"Cancer Discov"},{"key":"2178_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/0008-5472.CAN-15-0361","volume":"76","author":"T Ishiguro","year":"2016","unstructured":"Ishiguro T, Sato A, Ohata H, Ikarashi Y, Takahashi R-U, Ochiya T, et al. Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. Cancer Res. 2016;76:150\u201360. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0361.","journal-title":"Cancer Res"},{"key":"2178_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","volume":"2","author":"N Phan","year":"2019","unstructured":"Phan N, Hong JJ, Tofig B, Mapua M, Elashoff D, Moatamed NA, et al. A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids. Commun Biol. 2019;2:78. https:\/\/doi.org\/10.1038\/s42003-019-0305-x.","journal-title":"Commun Biol"},{"key":"2178_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s13577-022-00827-w","volume":"36","author":"Y Ito","year":"2023","unstructured":"Ito Y, Kondo J, Masuda M, Matsuzaki S, Onuma K, Kanda M, et al. Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs. Hum Cell. 2023;36:752\u201361. https:\/\/doi.org\/10.1007\/s13577-022-00827-w.","journal-title":"Hum Cell"},{"key":"2178_CR26","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinforma Oxf Engl. 2018;34:i884\u201390. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR27","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinforma Oxf Engl. 2009;25:2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR28","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust GG, Hall IM. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinforma Oxf Engl. 2014;30:2503\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btu314.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR29","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins P. Sambamba: fast processing of NGS alignment formats. Bioinforma Oxf Engl. 2015;31:2032\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/btv098.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139. https:\/\/doi.org\/10.1038\/nbt.2514.","journal-title":"Nat Biotechnol"},{"key":"2178_CR31","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WSW, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinforma Oxf Engl. 2012;28:1811\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bts271.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bioinformatics\/btr670","volume":"28","author":"V Boeva","year":"2012","unstructured":"Boeva V, Popova T, Bleakley K, Chiche P, Cappo J, Schleiermacher G, et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinforma Oxf Engl. 2012;28:423\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btr670.","journal-title":"Bioinforma Oxf Engl"},{"key":"2178_CR33","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. https:\/\/doi.org\/10.1093\/nar\/gkq603.","journal-title":"Nucleic Acids Res"},{"key":"2178_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-018-0539-0","volume":"10","author":"F Blokzijl","year":"2018","unstructured":"Blokzijl F, Janssen R, van Boxtel R, Cuppen E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 2018;10:33. https:\/\/doi.org\/10.1186\/s13073-018-0539-0.","journal-title":"Genome Med"},{"key":"2178_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/0264-6021:3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95\u2013105. https:\/\/doi.org\/10.1042\/0264-6021:3510095.","journal-title":"Biochem J"},{"key":"2178_CR36","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauv\u00e9 C-EG, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25:1607\u201314. https:\/\/doi.org\/10.1038\/s41591-019-0584-2.","journal-title":"Nat Med"},{"key":"2178_CR37","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","volume":"10","author":"D Sha","year":"2020","unstructured":"Sha D, Jin Z, Budczies J, Kluck K, Stenzinger A, Sinicrope FA. Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors. Cancer Discov. 2020;10:1808\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0522.","journal-title":"Cancer Discov"},{"key":"2178_CR38","doi-asserted-by":"publisher","first-page":"D863","DOI":"10.1093\/nar\/gkz964","volume":"48","author":"S-H Liu","year":"2020","unstructured":"Liu S-H, Shen P-C, Chen C-Y, Hsu A-N, Cho Y-C, Lai Y-L, et al. DriverDBv3: a multi-omics database for cancer driver gene research. Nucleic Acids Res. 2020;48:D863\u201370. https:\/\/doi.org\/10.1093\/nar\/gkz964.","journal-title":"Nucleic Acids Res"},{"key":"2178_CR39","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/life13081689","volume":"13","author":"A Matsas","year":"2023","unstructured":"Matsas A, Stefanoudakis D, Troupis T, Kontzoglou K, Eleftheriades M, Christopoulos P, et al. Tumor Markers and Their Diagnostic Significance in Ovarian Cancer. Life Basel Switz. 2023;13:1689. https:\/\/doi.org\/10.3390\/life13081689.","journal-title":"Life Basel Switz"},{"key":"2178_CR40","doi-asserted-by":"publisher","first-page":"1399502","DOI":"10.3389\/fonc.2024.1399502","volume":"14","author":"J Huang","year":"2024","unstructured":"Huang J, Du D, Chen H, Luo D, Wang Q, Li C, et al. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study. Front Oncol. 2024;14:1399502. https:\/\/doi.org\/10.3389\/fonc.2024.1399502.","journal-title":"Front Oncol"},{"key":"2178_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00280-002-0471-1","volume":"50","author":"R Yamamoto","year":"2002","unstructured":"Yamamoto R, Kaneuchi M, Nishiya M, Todo Y, Takeda M, Okamoto K, et al. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer. Cancer Chemother Pharmacol. 2002;50:137\u201342. https:\/\/doi.org\/10.1007\/s00280-002-0471-1.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2178_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.26.605381","author":"KM Adams","year":"2024","unstructured":"Adams KM, Wendt J-R, Wood J, Olson S, Moreno R, Jin Z, et al. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models. BioRxiv Prepr Serv Biol. 2024. https:\/\/doi.org\/10.1101\/2024.07.26.605381. 2024.07.26.605381.","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"2178_CR43","doi-asserted-by":"publisher","first-page":"19431","DOI":"10.1038\/s41598-025-03242-x","volume":"15","author":"FN Kalkan","year":"2025","unstructured":"Kalkan FN, Yildiz MS, Wood NE, Farid M, McCoy M, Lin MM, et al. Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines. Sci Rep. 2025;15:19431. https:\/\/doi.org\/10.1038\/s41598-025-03242-x.","journal-title":"Sci Rep"},{"key":"2178_CR44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1535-7163.MCT-23-0642","volume":"23","author":"SC Patterson","year":"2024","unstructured":"Patterson SC, Pomeroy AE, Palmer AC. Ultrasensitive Response Explains the Benefit of Combination Chemotherapy Despite Drug Antagonism. Mol Cancer Ther. 2024;23:995\u20131009. https:\/\/doi.org\/10.1158\/1535-7163.MCT-23-0642.","journal-title":"Mol Cancer Ther"},{"key":"2178_CR45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-3819","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xie H, Chang X, Hu W, Li M, Li Y, et al. Single-cell dissection of the multiomic landscape of high-grade serous ovarian cancer. Cancer Res. 2022. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-3819. CAN-21-3819.","journal-title":"Cancer Res"},{"key":"2178_CR46","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, et al. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020;26:1271\u20139. https:\/\/doi.org\/10.1038\/s41591-020-0926-0.","journal-title":"Nat Med"},{"key":"2178_CR47","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","volume":"28","author":"EL Christie","year":"2017","unstructured":"Christie EL, Bowtell DDL. Acquired chemotherapy resistance in ovarian cancer. Ann Oncol Off J Eur Soc Med Oncol. 2017;28:viii13\u20135. https:\/\/doi.org\/10.1093\/annonc\/mdx446.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2178_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","volume":"58","author":"W Senkowski","year":"2023","unstructured":"Senkowski W, Gall-Mas L, Falco MM, Li Y, Lavikka K, Kriegbaum MC, et al. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. Dev Cell. 2023;58:1106\u2013e11217. https:\/\/doi.org\/10.1016\/j.devcel.2023.04.012.","journal-title":"Dev Cell"},{"key":"2178_CR49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41467-019-14219-6","volume":"11","author":"Y Yasumizu","year":"2020","unstructured":"Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020;11:338. https:\/\/doi.org\/10.1038\/s41467-019-14219-6.","journal-title":"Nat Commun"},{"key":"2178_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/1541-7786.MCR-21-0672","volume":"20","author":"A Bhattacharya","year":"2022","unstructured":"Bhattacharya A, Fushimi A, Yamashita N, Hagiwara M, Morimoto Y, Rajabi H, et al. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells. Mol Cancer Res MCR. 2022;20:556\u201367. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0672.","journal-title":"Mol Cancer Res MCR"},{"key":"2178_CR51","doi-asserted-by":"publisher","first-page":"e2503545","DOI":"10.1002\/advs.202503545","volume":"12","author":"S Li","year":"2025","unstructured":"Li S, Dong X, Gao K, Wang Y, Li M, Deng H, et al. PP2A Promotes the Symmetric Division of MUC1-Dominant Cancer Stem-Like Cells in Small Cell Lung Cancer. Adv Sci Weinh Baden-Wurtt Ger. 2025;12:e2503545. https:\/\/doi.org\/10.1002\/advs.202503545.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2178_CR52","doi-asserted-by":"publisher","first-page":"101083","DOI":"10.1016\/j.neo.2024.101083","volume":"59","author":"L Staffeldt","year":"2025","unstructured":"Staffeldt L, Maar H, Beimdiek J, Chambers S, Riecken K, von Itzstein M, et al. Depletion of \u03b21,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells. Neoplasia N Y N. 2025;59:101083. https:\/\/doi.org\/10.1016\/j.neo.2024.101083.","journal-title":"Neoplasia N Y N"},{"key":"2178_CR53","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/cancers15072154","volume":"15","author":"A Natoni","year":"2023","unstructured":"Natoni A, Cerreto M, De Propris MS, Petrucci MT, Fazio F, Intoppa S, et al. Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity. Cancers. 2023;15:2154. https:\/\/doi.org\/10.3390\/cancers15072154.","journal-title":"Cancers"},{"key":"2178_CR54","doi-asserted-by":"publisher","first-page":"e2101176","DOI":"10.1002\/advs.202101176","volume":"8","author":"P Chen","year":"2021","unstructured":"Chen P, Zhang X, Ding R, Yang L, Lyu X, Zeng J, et al. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer. Adv Sci Weinh Baden-Wurtt Ger. 2021;8:e2101176. https:\/\/doi.org\/10.1002\/advs.202101176.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2178_CR55","doi-asserted-by":"publisher","first-page":"101838","DOI":"10.1016\/j.xcrm.2024.101838","volume":"5","author":"M Shi","year":"2024","unstructured":"Shi M, Yang Y, Huang N, Zeng D, Mo Z, Wang J, et al. Genetic and microenvironmental evolution of colorectal liver metastases under chemotherapy. Cell Rep Med. 2024;5:101838. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101838.","journal-title":"Cell Rep Med"},{"key":"2178_CR56","doi-asserted-by":"publisher","first-page":"111957","DOI":"10.1016\/j.jtbi.2024.111957","volume":"595","author":"F Padovano","year":"2024","unstructured":"Padovano F, Villa C. The development of drug resistance in metastatic tumours under chemotherapy: An evolutionary perspective. J Theor Biol. 2024;595:111957. https:\/\/doi.org\/10.1016\/j.jtbi.2024.111957.","journal-title":"J Theor Biol"},{"key":"2178_CR57","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1038\/s41467-025-59397-8","volume":"16","author":"A Khalil","year":"2025","unstructured":"Khalil A, Supek F. DiffInvex identifies evolutionary shifts in driver gene repertoires during tumorigenesis and chemotherapy. Nat Commun. 2025;16:4209. https:\/\/doi.org\/10.1038\/s41467-025-59397-8.","journal-title":"Nat Commun"},{"key":"2178_CR58","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. Cell Stem Cell. 2018;23:882\u2013e89711. https:\/\/doi.org\/10.1016\/j.stem.2018.09.016.","journal-title":"Cell Stem Cell"},{"key":"2178_CR59","doi-asserted-by":"publisher","first-page":"e70012","DOI":"10.1002\/ctm2.70012","volume":"14","author":"GYQ Han","year":"2024","unstructured":"Han GYQ, Alexander M, Gattozzi J, Day M, Kirsch E, Tafreshi N, et al. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment. Clin Transl Med. 2024;14:e70012. https:\/\/doi.org\/10.1002\/ctm2.70012.","journal-title":"Clin Transl Med"},{"key":"2178_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nmeth.4535","volume":"15","author":"AA Duarte","year":"2018","unstructured":"Duarte AA, Gogola E, Sachs N, Barazas M, Annunziato S, R de Ruiter J, et al. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance. Nat Methods. 2018;15:134\u201340. https:\/\/doi.org\/10.1038\/nmeth.4535.","journal-title":"Nat Methods"},{"key":"2178_CR61","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/1878-0261.70051","volume":"19","author":"G Gudoityte","year":"2025","unstructured":"Gudoityte G, Sharma O, Leuenberger L, Wallin E, Fernebro J, \u00d6stling P, et al. Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancer. Mol Oncol. 2025;19:2574\u201393. https:\/\/doi.org\/10.1002\/1878-0261.70051.","journal-title":"Mol Oncol"},{"key":"2178_CR62","doi-asserted-by":"publisher","first-page":"114656","DOI":"10.1016\/j.yexcr.2025.114656","volume":"450","author":"Y Ma","year":"2025","unstructured":"Ma Y, Xue F, Pei Z, Zhao Y. Constructing a co-culture model of cancer-associated fibroblasts and ovarian cancer organoids and studying mechanisms of drug resistance. Exp Cell Res. 2025;450:114656. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114656.","journal-title":"Exp Cell Res"},{"key":"2178_CR63","doi-asserted-by":"publisher","first-page":"165754","DOI":"10.1016\/j.bbadis.2020.165754","volume":"1866","author":"AC Dhadve","year":"2020","unstructured":"Dhadve AC, Hari K, Rekhi B, Jolly MK, De A, Ray P. Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165754. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165754.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2178_CR64","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1158\/0008-5472.CAN-24-2492","volume":"85","author":"S Zhou","year":"2025","unstructured":"Zhou S, Zhang Y, Belmar J, Hou C, Zhang Y, Peng C, et al. Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4\/6 Inhibitors in Breast Cancer. Cancer Res. 2025;85:1708\u201324. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2492.","journal-title":"Cancer Res"},{"key":"2178_CR65","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/s41401-021-00847-6","volume":"43","author":"C Shu","year":"2022","unstructured":"Shu C, Zheng X, Wuhafu A, Cicka D, Doyle S, Niu Q, et al. Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells. Acta Pharmacol Sin. 2022;43:2419\u201328. https:\/\/doi.org\/10.1038\/s41401-021-00847-6.","journal-title":"Acta Pharmacol Sin"},{"key":"2178_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ijc.34908","volume":"155","author":"P Hol\u00fd","year":"2024","unstructured":"Hol\u00fd P, Hlav\u00e1\u010d V, \u0160eborov\u00e1 K, \u0160\u016fsov\u00e1 S, Tesa\u0159ov\u00e1 T, Rob L, et al. Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. Int J Cancer. 2024;155:104\u201316. https:\/\/doi.org\/10.1002\/ijc.34908.","journal-title":"Int J Cancer"},{"key":"2178_CR67","doi-asserted-by":"publisher","first-page":"701429","DOI":"10.3389\/fcell.2021.701429","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Huang S, Cheng S, Jin Y, Zhang N, Wang Y. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities. Front Cell Dev Biol. 2021;9:701429. https:\/\/doi.org\/10.3389\/fcell.2021.701429.","journal-title":"Front Cell Dev Biol"},{"key":"2178_CR68","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.stem.2024.04.018","volume":"31","author":"TI Maulana","year":"2024","unstructured":"Maulana TI, Teufel C, Cipriano M, Roosz J, Lazarevski L, van den Hil FE, et al. Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells. Cell Stem Cell. 2024;31:989\u2013e10029. https:\/\/doi.org\/10.1016\/j.stem.2024.04.018.","journal-title":"Cell Stem Cell"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02178-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:51:18Z","timestamp":1789696278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02178-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02178-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and had patients\u2019 informed consent. On November 28, 2023, the Ethics Committee of Chongqing University Cancer Hospital approved the study titled \u201cExploratory Study on the Guidance of Organoid Drug Sensitivity Testing for the Precise Treatment of Recurrent Ovarian Cancer\u201d (Approval No.: CZLS2020274 - A). Every human participant provide their consent in the study. We ensured the protection of their privacy.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication has been obtained from all participants, and we have taken measures to protect their anonymity.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}